SPLDExtraTrees: Robust machine learning approach for predicting kinase
  inhibitor resistance
  Drug resistance is a major threat to the global health and a significant
concern throughout the clinical treatment of diseases and drug development. The
mutation in proteins that is related to drug binding is a common cause for
adaptive drug resistance. Therefore, quantitative estimations of how mutations
would affect the interaction between a drug and the target protein would be of
vital significance for the drug development and the clinical practice.
Computational methods that rely on molecular dynamics simulations, Rosetta
protocols, as well as machine learning methods have been proven to be capable
of predicting ligand affinity changes upon protein mutation. However, the
severely limited sample size and heavy noise induced overfitting and
generalization issues have impeded wide adoption of machine learning for
studying drug resistance. In this paper, we propose a robust machine learning
method, termed SPLDExtraTrees, which can accurately predict ligand binding
affinity changes upon protein mutation and identify resistance-causing
mutations. Especially, the proposed method ranks training data following a
specific scheme that starts with easy-to-learn samples and gradually
incorporates harder and diverse samples into the training, and then iterates
between sample weight recalculations and model updates. In addition, we
calculate additional physics-based structural features to provide the machine
learning model with the valuable domain knowledge on proteins for this
data-limited predictive tasks. The experiments substantiate the capability of
the proposed method for predicting kinase inhibitor resistance under three
scenarios, and achieves predictive accuracy comparable to that of molecular
dynamics and Rosetta methods with much less computational costs.
